QVT Associates GP LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), bought 1,963,248 shares at $6.32 ($12.6M) on 2013-07-03, disclosed to the SEC on 2013-07-05.
Open-market purchase of $12.6M ACHN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.30 | 150,000 | $945K | 7.5% |
| 2 | $6.31 | 50,000 | $316K | 2.5% |
| 3 | $6.51 | 1,300,000 | $8.5M | 67.1% |
| 4 | $6.24 | 442,737 | $2.8M | 21.9% |
| 5 | $6.32 | 20,511 | $130K | 1.0% |
| Total | $6.43 avg | 1,963,248 |
| $12.6M |
| 100% |
| Filing → |
| UROV | BUY | 2019-06-03 | $278K | — | Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $326K | — | Filing → |